Stay updated on IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers
Sign up to get notified when there's something new on the IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers page.

Latest updates to the IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers page
- Check6 days agoChange DetectedThe page now displays the clinical trial record, including its design, eligibility criteria, treatments, outcomes, and study dates, where an error screen appeared before.SummaryDifference43%

- Check13 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check20 days agoChange DetectedA notice appears explaining that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” and linking to related updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site’s revision identifier advances from v3.7.0 to v3.7.1; the page otherwise continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange Detected403 Forbidden error now appears on the page, replacing the study details. Access to the study record is blocked, and only a basic header and navigation are shown.SummaryDifference17%

Stay in the know with updates to IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers
Enter your email address, and we'll notify you when there's something new on the IMCISION Clinical Trial: Immunomodulation in Head and Neck Cancers page.